Transdermal drug delivery was infused with a new growth phase by nicotine patches used for smoking cessation. However, real growth in the global transdermal drug delivery market is now stemming from numerous innovative applications including but not limited to neurological disorders, pain management, hormone replacement therapy, contraception, and neurological disorders. All of these factors have played a role in the emergence of transdermal drug delivery system as one of the most lucrative and high-growth-potential markets within the drug delivery sector. These are the key findings of a new report by Transparency Market Research (TMR). The report is titled, “Transdermal Drug Delivery Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020.”
Transdermal drug delivery systems (TDDS) use the skin as a medium to deliver drugs slowly to patients. TDDS are fast emerging as an alternative to conventional drug administration methods such as pills, intravenous injections, and inhalation. A transdermal drug delivery system is composed of the following important components: the drug itself, permeation enhancers, the polymer mix, adhesives, and backing layers.
Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=158
Among the key growth drivers for the global transdermal drug delivery systems, the non-invasive nature of this drug delivery technique is emerging as the most important one. Another factor that wins TDDS the favor of medical practitioners and consumers alike is that it avoids first-pass metabolism. This helps enhance the drug’s bio-availability and alleviate any side effects associated with the drug. The drug delivery or therapy administration can be terminated at any time – a factor that has continued to aid the uptake of transdermal drug delivery systems.
The report segments the global transdermal drug delivery market basis application and geography. Based on application, the market has been split into hormone replacement therapy, contraception, pain management, smoking cessation, and neurological disorders. Nicotine patches have emerged as a high-value segment in the global transdermal drug delivery market, with sales in the U.S. reaching record highs in recent years.
From the geographical standpoint, the report segments the market into Asia Pacific, Europe, North America, and Rest of the World (which includes the Middle East and Africa and Latin America). Sales of transdermal drug delivery systems over the counter have shown a healthy increase in recent years, with nicotine patches being a profitable segment and vapor patches gaining to scale in Europe.
Companies that are currently at the forefront of the global transdermal drug delivery systems market include: 3M Pharmaceuticals Inc., Bayer Crop Science Ltd., Actelion Pharmaceuticals Ltd, Upsher-Smith Laboratories, Inc., BioGel Technology Inc., Mylan Pharmaceuticals Inc., Johnson & Johnson Limited, Novartis AG, GlaxoSmithKline plc, Noven Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Actavis Inc, and Boehringer Ingelheim GmbH.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453